08:50 Opening Remark from Chairperson

09:00 Minimising Vaccine Damage During Distribution

• Explaining WHO guidelines to maintain vaccine safety and potency during transportation
• Avoiding the risk of vaccine damage by preventing vaccine freezing during storage
• Identifying the required measures to prevent vaccines freezing during distribution

Robert Jin
Logistics Manager, China
Life Technologies

09:40 Biologics Add Complexity to Cold Chain Distribution: Are You Meticulous Enough?

• Addressing the “unknown unknowns” of cold chain transportation
• The importance of rigorously measuring and continuously improving processes for biologics/vaccines
• How to reduce cost, improve overall quality, and ensure regulatory compliance through a centrally integrated data portal
• Case studies with supporting data and analysis

Gordon Johnson
Head of Strategic Innovation
LifeConEx, LLC

10:20 Understanding the Challenges of Cold Chain System For New Vaccines

• Explaining the capacity of the existing cold chain
• Identifying the need for expanding the existing capacity to accommodate new vaccines
• Learning about the different tools to expand and improve your current cold chain system
• Explaining the need for a national cold chain assessment system to overcome cold chain system challenges

Viliam Kovac
VP Global Quality & Divisional Export Control
Roche

11:20 Implementing Cost-Effective Solutions in Handling Cold Chain Challenges in China

• Identifying and analysing challenges facing manufacturers and distributors in handling cold chain in China
• Overcoming challenges facing front line staff in the mid to last mile
• Explaining the recommended steps for improvements at regulations, customs, warehousing and distribution areas
• Using quality agreement as a tool for continuously improving the cold chain for pharmaceuticals

Guy Meeus
Director of Manufactuing
Johnson & Johnson China

12:00 Key considerations when managing cold chain

James Lee
VP Medical Devices
Cardinal Health

13:40 Exploring WHO Effective Vaccine Management Assessment in Developing Countries

• Enhancing your ability to validate vaccine shipment containers
• Understanding paper trail qualification for cold chain logistics and integrating third party monitoring
• Explaining auditing outcomes and improvement plan implementation

Michael Lee
Senior Vice President, Manufacturing & Project
Shanghai Biomabs Pharmaceuticals

15:00 Case Study: Understanding Cold Chain Related Deviations in the Pharmaceutical Industry

• Discussing the latest case studies of the most common deviations related to cold chain
• Allocating the key causes related to these deviations
• Learning how to avoid recurrence of similar deviation in the pharmaceutical cold chain

Hu Ying
General Manager
Shanghai Pharmaceuticals Logistics Center

15:40 Panel Discussion: Securing the Delivery of High Quality Pharmaceuticals

• Understanding product requirement to select the appropriate quality assurance tools
• Implementing value added activities to ensure the required quality of the product
• Defining stability parameters across the cold chain

Panellist:

16:20 Interactive Roundtable Discussion

Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others. The roundtable session lasts for 30 minutes, and topics discussed include:

• Maintaining the quality of temperature sensitive pharmaceutical products throughout the transportation environment
• Addressing new technologies to increase cold chain visibility

17:00 Keeping it Cool – Key Considerations When Ensuring Cold Chain Robustness

Masih Sabet
Sr. GMP Compliance, Project Execution
NNE Pharmaplan

17:30 Closing Remarks from Chairperson and End of Conference